Financials
- Market Capitalization 3.75 B
- Employee 975
- Founded 2007
- CEO N/A
- Website www.iovance.com
- Headquarter Delaware, United States
- FIGI BBG000FTLBV7
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
0.03
Rapporto prezzo/fatturato
0.01
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1535 | TNGX Tango Therapeutics, Inc. - Common Stock | 22.35 USD | -2.15% | -9.33% | -16.70% | +237.61% | 3.77 B USD | ||
| 1536 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 33.81 USD | +0.18% | -8.94% | +66.63% | +239.80% | 3.77 B USD | ||
| 1543 | DNLI Denali Therapeutics Inc. - Common Stock | 23.27 USD | -2.06% | -5.98% | +1.84% | +43.91% | 3.72 B USD | ||
| 1555 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.85 USD | -2.16% | -4.32% | +6.37% | +71.95% | 3.68 B USD |